Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
41 participants
OBSERVATIONAL
2021-12-17
2024-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Task Control Circuit Targets for Obsessive Compulsive Behaviors in Children
NCT03584945
Neurobiology of Sensory Phenomena in Obsessive-Compulsive Disorder
NCT03451409
Cortical Excitability in Obsessive-Compulsive and Related Disorders
NCT00029068
Reinforcement Learning and Obsessive-compulsive Disorder: Exploring the Role of the Orbitofrontal Cortex
NCT06566781
Using Online Delivered Therapy and Brain Imaging to Better Understand OCD
NCT04630197
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individuals diagnosed with OCD
Individuals diagnosed with OCD
No interventions assigned to this group
Healthy controls
Individuals who have not been diagnosed with any psychiatric disorders
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English-speaking
* Capacity to provide informed consent
* Primary diagnosis of OCD with at least moderate severity
Exclusion Criteria
* History of any significant medical condition that may increase the risk of participation
* Alcohol or substance use disorder in the past year
* Exposure and response prevention for OCD within the last six weeks
* Currently taking psychotropic medication
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International OCD Foundation
UNKNOWN
Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amy Rapp
Assistant Professor of Clinical Medical Psychology (in Psychiatry)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amy Rapp, PhD
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York State Psychiatric Institute
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7867
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.